Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience.
Espírito Santo V, Passos J, Nzwalo H, Carvalho I, Santos F, Martins C, Salgado L, Silva CE, Vinhais S, Vilares M, Salgado D, Nunes S.
Espírito Santo V, et al. Among authors: santos f.
J Neurooncol. 2020 Apr;147(2):459-463. doi: 10.1007/s11060-020-03443-6. Epub 2020 Feb 27.
J Neurooncol. 2020.
PMID: 32108293
Clinical Trial.